Synpromics Promoter Technology moves closer to the clinic
David Venables wins Disruptor category of EY Entrepreneur 2018
Synpromics receives £1.9m grant from Scottish Enterprise
Synpromics UCL partnership to develop novel gene therapies
Synpromics wins best emerging UK synthetic biotech company at 9th annual OBN Awards
Synpromics and Solid Biosciences gene therapy research partnership
Synpromics expands facilities to meet demand for revolutionary gene control technology
Engineering biology approaches for enhanced gene control in bioprocessing and therapeutic applications
Synpromics and GE Healthcare to extend the biologics production toolbox
Synpromics announces expansion of research collaboration with Adverum Biotechnologies
Synpromics collaborates with Sartorius Stedim Cellca to develop improved biologicals manufacturing process using synthetic promoters
Cell Therapy Catapult and Synpromics to develop large-scale viral vector manufacturing platform
